BIMI International Medical Inc.

BIMIOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$1156

P/E Ratio—

52W High$0.01

52W Low$0.0001

Avg Volume678

Open$0.00

Beta-0.58

Free Cash Flow Financials Revenue

BIMI International Medical Inc. (BIMI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BIMI · free cash flow · updated Jun 8, 2026

Core FCF metrics

BIMI · FCF · TTM · margin & CAGR

Free cash flow was −$10.3M for FY2022 (fiscal year ending 2022-12-31), down 390.6% year-over-year The FCF margin was -86.7%.

FY2022 Free Cash Flow−$10.3M▼ -390.6% YoY

Trailing 12M (TTM)−$2.8Mtrailing 4 quarters sum

FCF Margin-86.7%−$10.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BIMI · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$10.3M(0M)−$10.3M▼ 390.6%-86.7%

FY2021−$1.3M(1M)−$2.1M▲ +44.6%-9.8%

FY2020−$3.5M(0M)−$3.8M▼ 82.9%-29.4%

FY2019−$2.1M(0M)−$2.1M▼ 500.3%—

FY2018−$343,970(0M)−$343,970▲ +62.1%-5.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BIMI · P/FCF · FCF yield · FCF per share

BIMI International Medical Inc. (BIMI) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

BIMI · cash flow statement · operating / investing / financing

For FY2022, BIMI International Medical Inc. generated −$10.3M in operating cash flow and spent 0M in capital expenditures, yielding −$10.3M in free cash flow.

Operating Activities

−$10.3M

Cash from core business operations

2022-12-31

Investing Activities

−$0.5M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

+$8.4M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$10.3M) − |CapEx| (0M) = FCF (−$10.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

BIMI vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

BIMI International Medical Inc.YOU

BIMI

−$10.3M-390.6%-86.7%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

BIMI International Medical Inc. (BIMI) reported free cash flow of −$10.3M for FY2022 (fiscal year ending 2022-12-31), down 390.6% year-over-year. The FCF margin was -86.7%.

Based on available data, BIMI International Medical Inc. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $3.5M in FY2012.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BIMI free cash flow · 8 questions

BIMI International Medical Inc. free cash flow was −$10.3M for FY2022, down 390.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$2.8M.

BIMI free cash flowBIMI FCFBIMI FCF 2022BIMI free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · BIMI International Medical Inc. · BIMI International Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026